page list analyst
bullish
bullish technic momentum
stock bofaml life scienc diagnost team head derik de bruin
discuss technic indic offer fundament view expect
technic remain posit show absolut price
uptrend bullish rel price momentum aka leadership well-align
bullish fundament view set favor go earn
align expect high align deliv
technic remain bullish support near
potenti sustain break-out june high ralli toward
fundament expect elev follow bullish analyst day may
recent string out-performance follow channel check see anoth
strong print earn given posit momentum recent product innov
 geograph expans scanner busi look case shipment
survey show oppi averag risk penetr
technic bullish breakout/retest pattern
favor upsid
fundament conduct cologuard survey respond
re-evalu colorect cancer screen market long-term opportun
cologuard cg rais base case peak penetr averag risk
popul lead new po refer companion note survey
upsid guid analyst day key catalyst
technic bullish approach long-term project
favor buy dip hold support
fundament investor becom comfort new landscap ah
dx aftermath zts/abax acquisit link view setup
favor rest particularli easi comp
see addit catalyst august analyst day companion note
quarterli preview anim health space rais po
sequenc consum growth focu
technic show first support broke base earlier
year upsid potenti
fundament novaseq product cycl second year instal base
continu expand believ investor focu shift sequenc consum
growth key metric perform head print expect
remain high feedback client indic yoy growth necessari
support valuat continu see multi-year runway novaseq product
cycl sustain total sale growth compound-annual-growth-rate rais po
higher est page report detail discuss
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
bullish technic momentum
technic hold case
technic hold case
fundament rais base case new po
technic bullish momentum look buy dip
fundament favor setup rest
technic base target
fundament multi-year runway novaseq
rais po higher estim
bullish technic momentum
technic remain posit show absolut price
uptrend bullish rel price momentum aka leadership process use weekli
chart elimin daili nois focu absolut price chart rel chart
vs use quarterli half year proxi
move averag identifi trend momentum leadership
equiti technic analysi teach-in sector stock move
flag key technic fundament
page follow
technic hold case
agln bullish momentum stock strong absolut rel price trend
achiev new weekli absolut rel high last week rule
backing-and-fil support near remain bullish
potenti decis break june high toward
would get much concern last higher low near broke
rise near would suggest deeper correct toward
rise prior high april-januari
expect elev follow bullish analyst day may recent
string out-performance follow channel check see anoth strong print
earn given posit momentum recent product innov geograph
expans scanner busi look case shipment growth yoy
chart rel bottom weekli chart
technic hold case
came bullish view themat stock chart jan
stock pull back expect confirm doubl bottom earli
june break-out doubl bottom target achiev
also rise bullish breakout/retest pattern
favor upsid
addit support come near bottom break-out point rise
week support give way
fundament rais base case new po
conduct cologuard survey respond re-evalu
colorect cancer screen market long-term opportun cologuard cg
rais base case peak penetr averag risk popul
lead new po refer companion note survey
chart exact scienc rel bottom weekli chart
technic bullish momentum look buy dip
show strong momentum new weekli absolut rel high last week
howev push top rise channel late near
suggest may get extend stock get closer longer-
term measur move project
favor buy dip support dip come june high/juli break-out
point june breakout/retest point/lat uptrend support rise
bullish near underpin support bullish trend
suggest support hold potenti addit new high
fundament favor setup rest
investor becom comfort new landscap ah dx
aftermath zts/abax acquisit link view setup
favor rest particularli easi comp see
addit catalyst august analyst day companion note quarterli
preview anim health space rais po
chart idexx laboratori rel bottom weekli chart
technic base target
show bullish momentum break-out base earlier year
sector stock move may suggest upsid measur
move pattern count key bull hold juli break-out point
dip decis break rise june
higher low would maintain strong price trend rel price high
vs juli key resist watch
fundament multi-year runway novaseq
novaseq product cycl second year instal base continu
expand believ investor focu shift sequenc consum growth
key metric perform head print expect remain high
feedback investor indic yoy growth necessari support
valuat continu see multi-year runway novaseq product cycl
sustain total sale growth compound-annual-growth-rate
rais po higher estim
rais estim model larg higher pull-through novaseq
consum line look sale yoy unchang
yoy higher est po goe still base
dcf analysi assum wacc approxim termin growth rate
chart inc rel bottom weekli chart
exact molecular diagnost compani focu cancer screen test exact
commerci next-gener non-invas colorect cancer screen
test cologuard cg receiv concomit fda approv medicar coverag
exact continu gain signific traction doctor patient payer
expect materi industry-lead growth profil long term
expect exact gener posit free cash flow cg scale
po base price-to-earnings line compani peer group
discount align current price-to-earnings multipl valuat also equat
ratio line high-grow premium asset healthcar
believ multipl justifi given strong growth profil substanti tam
opportun estimate sale compound-annual-growth-rate next five year
downsid risk price object competit exist new clear
align manufactur slower macroeconom condit multipl contract due
fund flow de-risk move
po base discount cash flow analysi assum roughli
penetr averag risk screen popul within next five
year exit penetr within next fifteen year termin
growth wacc po impli around above-consensu sale
estim roughli line stock one-year averag forward ev sale
multipl risk real perceiv slowdown cologuard ramp declin
risk real perceiv slowdown cologuard ramp declin complianc rate
price eros competit threat liquid biopsi screen test
share trade signific premium broader anim health peer
group histor level howev given mani posit secular product
tailwind compani current enjoy believ premium valuat justifi
po base ep estim in-lin histor trend
observ high growth life scienc diagnost tool compani broader
downsid risk po lower spend vet servic event
econom slowdown slower-than-expect uptak new product ou expans
competit lower-than-expect margin expans weather disrupt currenc
price object base dcf analysi assum wacc
approxim termin growth rate po approxim
revenu estim roughli ep estim consid
justifi given attract long-term outlook genom market compani
technolog leadership new product cycl increas penetr fast-
grow clinic appli market
downsid risk po weaker-than-expect academ fund lower
consum pull-through competit within genet analysi market regulatori
reimburs uncertainti clinic sequenc market acquisit integr
issu grow concern data privaci slower-than-expect uptak new
stephen suttmeier cfa cmt derik de bruin michael ryskin herebi certifi
view us express research report accur reflect
respect person view subject secur issuer also
certifi part respect compens directli
indirectli relat specif recommend view express research
becton dickinson compani
invest opinion system contain end report head fundament equiti opinion dark grey shade indic secur restrict opinion suspend medium grey
shade indic secur review opinion withdrawn grey shade indic secur cover chart current june later date indic
invest opinion system contain end report head fundament equiti opinion dark grey shade indic secur restrict opinion suspend medium grey
shade indic secur review opinion withdrawn grey shade indic secur cover chart current june later date indic
invest opinion system contain end report head fundament equiti opinion dark grey shade indic secur restrict opinion suspend medium grey
shade indic secur review opinion withdrawn grey shade indic secur cover chart current june later date indic
invest opinion system contain end report head fundament equiti opinion dark grey shade indic secur restrict opinion suspend medium grey
shade indic secur review opinion withdrawn grey shade indic secur cover chart current june later date indic
equiti invest rate distribut health group jun
equiti invest rate distribut global group jun
issuer invest bank client bofa merril lynch one affili within past month purpos invest rate distribut coverag univers includ stock
stock rate neutral includ hold stock rate under-perform includ sell
price fluctuat medium high invest rate reflect analyst assess stock absolut total return potenti ii
attract invest rel stock within coverag cluster defin three invest rate buy stock expect total
return least attract stock coverag cluster neutral stock expect remain flat increas valu less attract
buy rate stock under-perform stock least attract stock coverag cluster analyst assign invest rate consid among thing
month total return expect stock firm guidelin rate dispers shown tabl current price object stock
referenc better understand total return expect given time price object reflect analyst view potenti price appreci depreci
fundament equiti opinion opinion includ volatil risk rate invest rate incom rate volatil risk rate indic potenti
total return expect within period date initi rate
rate dispers guidelin coverag cluster
rate dispers may vari time time bofa merril lynch research believ better reflect invest prospect stock coverag cluster
incom rate indic potenti cash dividend same/high dividend consid secur same/low dividend consid secur pay
cash dividend coverag cluster compris stock cover singl analyst two analyst share common industri sector region classif stock
coverag cluster includ recent bofa merril lynch report referenc stock
price chart secur referenc research report avail http //pricechart baml com call mail
mlpf one affili act market maker equiti secur recommend report
mlpf affili manag public offer secur issuer within last month exact scienc
issuer within last month invest bank client mlpf and/or one affili exact scienc
mlpf affili receiv compens issuer non-invest bank servic product within past month
issuer within last month non-secur busi client mlpf and/or one affili
mlpf affili receiv compens invest bank servic issuer within past month exact scienc
mlpf affili expect receiv intend seek compens invest bank servic issuer affili issuer within next three month idexx
mlpf togeth affili benefici own one percent common stock issuer report issu day month reflect
ownership posit last day previou month report issu day month reflect ownership posit end second month preced date
report
mlpf one affili will sell buy client common equiti issuer princip basi
issuer within last month secur busi client non-invest bank mlpf and/or one affili
due natur strateg analysi issuer secur recommend discuss report continu follow accordingli investor must regard report
provid stand-alon analysi expect continu analysi addit report relat issuer and/or secur
due natur quantit analysi issuer secur recommend discuss report continu follow accordingli investor must regard report
provid stand-alon analysi expect continu analysi addit report relat issuer and/or secur
due natur technic analysi issuer secur recommend discuss report continu follow accordingli investor must regard report
provid stand-alon analysi expect continu analysi addit report relat issuer and/or secur
bofa merril lynch research personnel includ analyst respons report receiv compens base upon among factor overal profit america
corpor includ profit deriv invest bank analyst respons report may also receiv compens base upon among factor overal
profit bank sale trade busi relat class secur financi instrument analyst respons
bofa merril lynch fix incom analyst regularli interact sale trade desk personnel connect research includ ascertain price liquid fix
